Montco biopharm to collaborate with the Parker Institute for Cancer Immunotherapy – Philadelphia Business Journal
Philadelphia Business Journal |
Montco biopharm to collaborate with the Parker Institute for Cancer Immunotherapy
Philadelphia Business Journal The initial trial under consideration between Inovio (NASDAQ: INO) of Plymouth Meeting and the Parker Institute would address muscle invasive bladder cancer with an experimental immunotherapy product under development by Inovio in combination with … Inovio Pharmaceuticals and the Parker Institute for Cancer Immunotherapy Establish Clinical Development … |
